August 7, 2012 8:02 pm by Staff | 0 Comments
Achillon Pharmaceuticals Inc said its experimental hepatitis C drug showed promising interim data in a mid-stage trial, sending its shares higher in extended trade. The company said the drug sovaprevir, ...
Read more